Catheter for Complex PCI
Complex Percutaneous Coronary Intervention
Pre-clinicalActive
Key Facts
About NirvaMed
NirvaMed is a private, pre-revenue medical device company founded in 2018, developing a novel catheter technology for cardiology applications. Its primary focus is on a heart cooling therapy for STEMI heart attacks, with a strategic expansion into the complex PCI market. The company is currently raising financing to advance product development, conduct clinical studies, and pursue 510(k) clearance within a four-year timeline, while operating with a unique US-Thailand research and development model.
View full company profile